PEDIATRICS Vol. 8 No. 5 November 1951, pp. 730-733
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DARGEON, H.
Right arrow Articles by KIMBALL, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DARGEON, H.
Right arrow Articles by KIMBALL, E. R., JR.

Round Table Discussion

LEUKEMIA AND NEUROBLASTOMA

HAROLD DARGEON M.D.1, JOSEPH H. BURCHENAL M.D.2, CLAYTON T. J. DODGE M.D.1, and ERNEST R. KIMBALL JR. 1

1 The Chemotherapy Service of Memorial Hospital, New York City.
2 Damon Runyon Senior Clinical Research Fellow., The Chemotherapy Service of Memorial Hospital, New York City.

Neuroblastoma in common with many other tumors of the juvenile age period presents a diagnostic challenge to the clinician. The conditions should be included in the differential diagnosis of many acute and chronic syndromes in early childhood whether or not a tumor is clinically evident. The possibilities of a favorable result are not always determined solely by an early diagnosis but the prognosis in the occasional case of neuroblastoma may be favorably influenced by early recognition of the disease.